Recent publications

Weekly update on stem cells - Friday October 11th

Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases

Cai R, Zhang Y, Simmering JE, Schultz JL, Li Y, Fernandez-Carasa I, Consiglio A, Raya A, Polgreen PM, Narayanan NS, Yuan Y, Chen Z, Su W, Han Y, Zhao C, Gao L, Ji X, Welsh MJ, Liu L. (2019)

More information

Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes

Benzoni P, Campostrini G, Landi S, Bertini V, Marchina E, Iascone M, Ahlberg G, Olesen MS, Crescini E, Mora C, Bisleri G, Muneretto C, Ronca R, Presta M, Poliani PL, Piovani G, Verardi R, Pasquale ED, Consiglio A, Raya A, Torre E, Lodrini AM, Milanesi R, Rocchetti M, Baruscotti M, DiFrancesco D, Memo M, Barbuti A, Dell'Era P. (2019)

More information

Deconstructing the myth of poor prognosis for fast-cleaving embryos on day 3. Is it time to change the consensus?

Pons MC, Carrasco B, Parriego M, Boada M, González-Foruria I, Garcia S, Coroleu B, Barri PN, Veiga A. (2019)

More information

CLOSED - Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine

Last News

News

A research team develops a Mini-Factory of Human Cardiac Tissue

A system developed by researchers from the Institute for Bioengineering of Catalonia (IBEC) and the Centre of Regenerative Medicine in Barcelona (CMR[B]) is capable of producing tissues in a laboratory that simulate the behaviour of the human heart.

The tissues produced by this bioengineering system could be used to pre-evaluate the toxicity of drugs in the heart without using animal models.

More


© Center of Regenerative Medicine in Barcelona 2009-2019 - Legal note - Cookie Policy - Credits - Accessibility